Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GILEAD SCIENCES, INC. | Director | Common Stock | 24.5K | $1.59M | $64.92 | May 8, 2024 | Direct |
GILEAD SCIENCES, INC. | Director | Non-qualified Stock Option (Right to Buy) | 12.6K | May 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GILD | GILEAD SCIENCES, INC. | May 8, 2024 | 2 | $0 | 4 | May 9, 2024 | Director |
GILD | GILEAD SCIENCES, INC. | May 3, 2023 | 2 | $808K | 4 | May 4, 2023 | Director |
GILD | GILEAD SCIENCES, INC. | May 5, 2022 | 2 | $0 | 4 | May 6, 2022 | Director |
GILD | GILEAD SCIENCES, INC. | May 3, 2022 | 2 | $0 | 4 | May 3, 2022 | Director |
GILD | GILEAD SCIENCES INC | May 12, 2021 | 2 | $0 | 4 | May 14, 2021 | Director |
GILD | GILEAD SCIENCES INC | May 6, 2021 | 2 | $0 | 4 | May 7, 2021 | Director |